EVALUATION OF DIFFERENT IMMUNIZATION SCHEDULES FOR ORAL CHOLERA-B SUBUNIT-WHOLE CELL VACCINE IN SWEDISH VOLUNTEERS

被引:46
作者
JERTBORN, M [1 ]
SVENNERHOLM, AM [1 ]
HOLMGREN, J [1 ]
机构
[1] GOTHENBURG UNIV,DEPT INFECT DIS,S-41346 GOTHENBURG,SWEDEN
关键词
IMMUNIZATION INTERVAL; ORAL CHOLERA VACCINE; ANTITOXIN; VIBRIOCIDAL ANTIBODIES; BICARBONATE BUFFER;
D O I
10.1016/0264-410X(93)90125-H
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Different immunization schedules for oral B subunit-whole cell (B-WC) cholera vaccine were evaluated in Swedish volunteers to obtain information for recommendations of vaccine use in non-endemic areas. Two peroral doses of B-WC vaccine were as effective as three doses in inducing IgA and IgG antitoxin as well as vibriocidal antibody responses in serum. Administration of two vaccine doses either at 7, 14 or 28-42 day intervals resulted in comparable antitoxin responses in serum, whereas a 3-day immunization interval resulted in significantly lower titre increases. Vibriocidal antibody responses were comparable after the different time intervals tested (3-42 days). The B-WC vaccine can be effectively administered together with a cheap, commercially available sodium bicarbonate powder dissolved in water to protect the vaccine from gastric acid.
引用
收藏
页码:1007 / 1012
页数:6
相关论文
共 18 条
[1]   PROTECTIVE EFFICACY IN HUMANS OF KILLED WHOLE-VIBRIO ORAL CHOLERA VACCINE WITH AND WITHOUT THE B-SUBUNIT OF CHOLERA-TOXIN [J].
BLACK, RE ;
LEVINE, MM ;
CLEMENTS, ML ;
YOUNG, CR ;
SVENNERHOLM, AM ;
HOLMGREN, J .
INFECTION AND IMMUNITY, 1987, 55 (05) :1116-1120
[2]   B-SUBUNIT-WHOLE CELL AND WHOLE CELL-ONLY ORAL VACCINES AGAINST CHOLERA - STUDIES ON REACTOGENICITY AND IMMUNOGENICITY [J].
CLEMENS, JD ;
STANTON, BF ;
CHAKRABORTY, J ;
SACK, DA ;
KHAN, MR ;
HUDA, S ;
AHMED, F ;
HARRIS, JR ;
YUNUS, M ;
KHAN, MU ;
SVENNERHOLM, AM ;
JERTBORN, M ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (01) :79-85
[3]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS FROM 3-YEAR FOLLOW-UP [J].
CLEMENS, JD ;
SACK, DA ;
HARRIS, JR ;
VANLOON, F ;
CHAKRABORTY, J ;
AHMED, F ;
RAO, MR ;
KHAN, MR ;
YUNUS, M ;
HUDA, N ;
STANTON, BF ;
KAY, BA ;
WALTER, S ;
EECKELS, R ;
SVENNERHOLM, AM ;
HOLMGREN, J .
LANCET, 1990, 335 (8684) :270-273
[4]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - SERUM VIBRIOCIDAL AND ANTITOXIC ANTIBODIES AS MARKERS OF THE RISK OF CHOLERA [J].
CLEMENS, JD ;
VANLOON, F ;
SACK, DA ;
CHAKRABORTY, J ;
RAO, MR ;
AHMED, F ;
HARRIS, JR ;
KHAN, MR ;
YUNUS, M ;
HUDA, S ;
KAY, BA ;
SVENNERHOLM, AM ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1235-1242
[5]   EFFECT OF NEUTRALIZATION OF GASTRIC-ACID ON IMMUNE-RESPONSES TO AN ORAL-B SUBUNIT, KILLED WHOLE-CELL CHOLERA VACCINE [J].
CLEMENS, JD ;
JERTBORN, M ;
SACK, D ;
STANTON, B ;
HOLMGREN, J ;
KHAN, MR ;
HUDA, S .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (01) :175-178
[6]   CROSS-PROTECTION BY B-SUBUNIT WHOLE CELL CHOLERA VACCINE AGAINST DIARRHEA ASSOCIATED WITH HEAT-LABILE TOXIN PRODUCING ENTERO-TOXIGENIC ESCHERICHIA-COLI - RESULTS OF A LARGE-SCALE FIELD TRIAL [J].
CLEMENS, JD ;
SACK, DA ;
HARRIS, JR ;
CHAKRABORTY, J ;
NEOGY, PK ;
STANTON, B ;
HUDA, N ;
KHAN, MU ;
KAY, BA ;
KHAN, MR ;
ANSARUZZAMAN, M ;
YUNUS, M ;
RAO, MR ;
SVENNERHOLM, AM ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) :372-377
[7]   NEW CHOLERA VACCINES [J].
HOLMGREN, J ;
CLEMENS, J ;
SACK, DA ;
SVENNERHOLM, AM .
VACCINE, 1989, 7 (02) :94-96
[8]   DEVELOPMENT OF IMPROVED CHOLERA VACCINE BASED ON SUBUNIT TOXOID [J].
HOLMGREN, J ;
SVENNERHOLM, AM ;
LONNROTH, I ;
FALLPERSSON, M ;
MARKMAN, B ;
LUNDBECK, H .
NATURE, 1977, 269 (5629) :602-604
[9]  
HOLMGREN J, 1990, NEW GENERATION VACCI, P289
[10]   SALIVA, BREAST-MILK, AND SERUM ANTIBODY-RESPONSES AS INDIRECT MEASURES OF INTESTINAL IMMUNITY AFTER ORAL CHOLERA VACCINATION OR NATURAL DISEASE [J].
JERTBORN, M ;
SVENNERHOLM, AM ;
HOLMGREN, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (02) :203-209